List view / Grid view

Ablynx

 

news

Ablynx starts Phase III follow-up aTTP study

13 October 2016 | By Niamh Louise Marriott, Digital Content Producer

Acquired TTP is an acute, ultra-rare, life-threatening blood clotting disorder in which uncontrolled platelet aggregation and microclot formation cause...